Cargando…

Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis

PURPOSE: To summarize the 5-year outcomes of drug-coated balloon (DCB) for the treatment of femoropopliteal lesions in patients with diabetes mellitus (DM) or chronic limb-threatening ischemia (CLTI) compared to non-DM and intermittent claudication (IC). METHODS: The IN.PACT Global study was a real-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reijnen, Michel M. P. J., van Wijck, Iris, Brodmann, Marianne, Micari, Antonio, Torsello, Giovanni, Rha, Seung-Woon, Menk, Jeremiah, Zeller, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547845/ https://www.ncbi.nlm.nih.gov/pubmed/37526706 http://dx.doi.org/10.1007/s00270-023-03478-y

Ejemplares similares

Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study
por: Reijnen, Michel M. P. J., et al.
Publicado: (2019)

Long-Term Outcomes of the 150 mm Drug-Coated Balloon Cohort from the IN.PACT Global Study
por: Brodmann, Marianne, et al.
Publicado: (2022)

Long‐term outcomes after paclitaxel‐coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study
por: Ko, Young‐Guk, et al.
Publicado: (2022)

Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study
por: Ansel, Gary M., et al.
Publicado: (2018)

Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial
por: Schneider, Peter A., et al.
Publicado: (2018)

Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions: Five-Year Outcomes From the IN.PACT SFA Randomized Trial
por: Laird, John A., et al.
Publicado: (2019)

IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial
por: Zeller, Thomas, et al.
Publicado: (2014)

IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population
por: Chen, Zhong, et al.
Publicado: (2019)

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: 12-Month Results From the IN.PACT SFA Randomized Trial
por: Tepe, Gunnar, et al.
Publicado: (2015)

IN.PACT™ Admiral™ drug-coated balloons in peripheral artery disease: current perspectives
por: Torii, Sho, et al.
Publicado: (2019)

Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort
por: Torsello, Giovanni, et al.
Publicado: (2020)

Three-Year Results of the IN.PACT SFA Japan Trial Comparing Drug-Coated Balloons With Percutaneous Transluminal Angioplasty
por: Soga, Yoshimitsu, et al.
Publicado: (2020)

Economics of drug‐coated balloons for arteriovenous fistula stenosis in Japan and Korea based on the IN.PACT AV access trial
por: Chun, Ho Jong, et al.
Publicado: (2022)

Individual patient data meta‐analysis of patients treated with a heparin‐bonded Viabahn in the femoropopliteal artery for chronic limb‐threatening ischemia
por: Groot Jebbink, Erik, et al.
Publicado: (2022)

Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics
por: Du, Xin, et al.
Publicado: (2019)

Intravascular Lithotripsy and Drug-Coated Balloon Angioplasty for Severely Calcified Femoropopliteal Arterial Disease
por: Stavroulakis, Konstantinos, et al.
Publicado: (2022)

Paclitaxel exposure: Long‐term safety and effectiveness of a drug‐coated balloon for claudication in pooled randomized trials
por: Schneider, Peter A., et al.
Publicado: (2020)

Low-Dose Paclitaxel–Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon)
por: Schroeder, Henrik, et al.
Publicado: (2017)

Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
por: Teichgräber, Ulf, et al.
Publicado: (2021)

Evaluation of an interactive program for preventing adverse drug events in primary care: study protocol of the InPAct cluster randomised stepped wedge trial
por: Keriel-Gascou, Maud, et al.
Publicado: (2013)

COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions
por: Steiner, Sabine, et al.
Publicado: (2020)

Propensity score-matched analysis of six-month outcomes of paclitaxel-coated balloons combined with UltraScore balloons versus conventional scoring balloons for femoropopliteal lesions
por: Haraguchi, Takuya, et al.
Publicado: (2023)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries
por: Pastromas, Georgios, et al.
Publicado: (2014)

Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study
por: Schroë, Herman, et al.
Publicado: (2017)

Critical appraisal of paclitaxel balloon angioplasty for femoral–popliteal arterial disease
por: Herten, Monika, et al.
Publicado: (2016)

Combination of Rotational Atherothrombectomy and Paclitaxel-Coated Angioplasty for Femoropopliteal Occlusion
por: Scheer, F, et al.
Publicado: (2015)

Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019)

Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease
por: Müller-Hülsbeck, Stefan, et al.
Publicado: (2016)

Twelve-Month Results From the First-in-China Prospective, Multi-Center, Randomized, Controlled Study of the FREEWAY Paclitaxel-Coated Balloon for Femoropopliteal Treatment
por: Zhang, Bihui, et al.
Publicado: (2021)

Vessel Patency and Associated Factors of Drug‐Coated Balloon for Femoropopliteal Lesion
por: Soga, Yoshimitsu, et al.
Publicado: (2022)

Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies
por: Krishnan, Prakash, et al.
Publicado: (2017)

BioMimics 3D Stent in Femoropopliteal Lesions: 3-Year Outcomes with Propensity Matching for Drug-Coated Balloons
por: Piorkowski, Michael, et al.
Publicado: (2023)

Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Katsanos, Konstantinos, et al.
Publicado: (2018)

Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials
por: Klumb, Christof, et al.
Publicado: (2019)

Paclitaxel-coated balloons angioplasties for extra-long femoropopliteal artery atherosclerotic lesions (> 30 cm):12 months outcomes from a single center
por: Pan, Tao, et al.
Publicado: (2022)

A Budget Impact Model for Paclitaxel-eluting Stent in Femoropopliteal Disease in France
por: De Cock, Erwin, et al.
Publicado: (2012)

Production of human vitronectin in Nicotiana benthamiana using the INPACT hyperexpression platform
por: Dugdale, Benjamin, et al.
Publicado: (2017)

Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
por: Shirai, Shigemitsu, et al.
Publicado: (2022)

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial
por: Dake, Michael D., et al.
Publicado: (2016)

Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry
por: Tepe, Gunnar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_02ofe4vpqapv83jflsm5pcrvef